Literature DB >> 31429742

C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study.

Hiroaki Tanaka1, Tatsuro Tamura2, Takahiro Toyokawa2, Kazuya Muguruma2, Naoshi Kubo2, Katsunobu Sakurai2, Masaichi Ohira2.   

Abstract

BACKGROUND: In gastrectomy, postoperative elevation of C-reactive protein (CRP) is thought to be useful for predicting complications. Laparoscopic gastrectomy (LG) is less invasive than laparotomy and the elevation of CRP is also mild. Postoperative complications such as anastomotic leakage not only increase the severity of the condition, but also carry a poor prognosis when treatment is delayed. Early treatment is therefore necessary.
METHOD: This retrospective study examined the relationship between occurrence of complications and the ratio of CRP levels on postoperative days 1 and 3 (CRP ratio) for 449 gastric cancer patients who underwent LG in the Department of Gastrointestinal Surgery at Osaka City University Hospital between 2006 and 2016.
RESULTS: We observed that factors associated with postoperative complications were preoperative renal failure and CRP ratio. No significant associations with surgical procedure, operation time, bleeding volume, age, obesity, measured CRP concentration, or white blood cell count were evident. The optimal cut-off for CRP ratio to predict postoperative complications from the receiver operating characteristic curve was 2.13.
CONCLUSION: Our results suggested that the risk of severe postoperative complications after LG could be predicted using the CRP ratio.

Entities:  

Keywords:  C-reactive protein; Gastric cancer; Laparoscopic gastrectomy; Postoperative complication

Mesh:

Substances:

Year:  2019        PMID: 31429742      PMCID: PMC6702707          DOI: 10.1186/s12893-019-0582-9

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


Introduction

Laparoscopic gastrectomy (LG) is widely accepted in East Asia as a minimally invasive surgery for gastric cancer [1]. The benefits of LG include reduced surgical trauma, pain and quick recovery [2, 3]. Postoperative complications, however, still occur even after LG, and the overall postoperative complication rate after gastrectomy has been reported as 7–28% [4-6]. Surgeons should recognize the risk of complications before the presentation of overt symptoms and seek early diagnosis, because complications after gastrectomy may adversely affect long- and short-term outcomes in patients [7-9]. With regard to gastrectomy, several investigators have reported a relationship between postoperative C-reactive protein elevation and complications [10-13]. However, those reports analyzed values from datasets that included open gastrectomy (OG). Suitable CRP-related values to predict postoperative complications after LG thus remain uncertain. We hypothesized that postoperatively elevated CRP concentrations would be predictive of postoperative complications after LG. The aim of this retrospective study was to investigate the elevation rate of CRP as an early predictor of postoperative complications after LG for gastric cancer.

Patients and methods

Patients and data collection

Data were obtained from 449 patients with histologically confirmed gastric cancer who had undergone LG with lymph node dissection between 2006 and 2016 in the Department of Surgical Oncology at Osaka City University. Stage and other information including macroscopic type, histology, depth of tumor (T), lymph node metastasis (N), distant metastasis (M), lavage cytology (CY), and lymphatic or venous involvement were classified according to the criteria of the 3rd edition of Japanese Classification of Gastric Carcinoma by the Japanese Gastric Cancer Association. Data for clinicopathological characteristics, intra-operative findings, and postoperative course were extracted from our database. The Clavien-Dindo (CD) classification was adopted for evaluating postoperative complications [14]. Complications were defined as those of CD grade II or higher, with complications of grade IIIa or higher considered severe. This retrospective study was approved by the ethics committee of Osaka City University (#4038) and carried out according to the Declaration of Helsinki. We collected laboratory data including white blood cell count (WBC), neutrophil count, lymphocyte count, and CRP concentration on postoperative days (POD)1 and POD3. The CRP ratio was defined as: (CRP concentration on POD3) / (CRP concentration on POD1).

Statistical analysis

Relationships between complications and other variables were analyzed using the Mann-Whitney U test. Uni- and multivariate logistic regression analyses were performed. Values of P < 0.05 were considered statistically significant. The cut-off value for the CRP ratio was determined using receiver operating characteristic (ROC) curves. Analysis was performed using JMP® version 11 software (SAS Institute, Cary, NC). The area under the curve and 95% confidence interval of the ROC curve and the power of this study were calculated using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria). More precisely, EZR is a modified version of R Commander designed to add statistical functions frequently used in biostatistics [15].

Results

Patient characteristics

Background characteristics of the cohort in this study are summarized in Table 1. Of the 449 patients, 41 (9.1%) were more than 80 years old, and 57 (12.6%) had a body mass index > 25 kg/m2. Some form of comorbidity was identified in 77 patients (17.1%), including diabetes mellitus, renal dysfunction, ischemic heart disease, brain infarction, liver cirrhosis, and chronic obstructive pulmonary disease. Twenty patients showed multiple comorbidities. Distal gastrectomy was performed for 393 patients (87.5%), and D2 lymph node dissection for 48 patients (10.6%). Mean intraoperative blood loss was 121 g and mean operation time was 283 min. Pathological results were stage I in 389 (86.6%) patients, stage II in 41 (9.3%), and stage III in 19 (4.2%). Median white blood cell count was 10,000/mm3 on POD1 and 7000/mm3 on POD3, and median CRP concentration was 5.8 mg/dL on POD1 and 7.3 mg/dL on POD3.
Table 1

Patients characteristics and difference between severe complitcation and no or mild complication

Total patients (n = 449)Severe Complication (n = 33)No or mild complication (n = 416)p value
Age
  ≤ 80408293790.535
  ≤ 8141437
Sex
 Male299272720.325
 Female1506144
BMI
  ≤ 25392273650.325
  > 2557651
Preoperative comorbidity
 DM6210520.004
 Renal dysfuction532< 0.001
 Ischemic heart disease284240.146
 Brain infarction252230.898
 Liver cirrhosis5050.526
 COPD141130.976
 Multiple Comorbidities203170.011
Operation time
 Average (min)2812802830.813
 Blood loss
 Average (g)1211241210.936
Surgery
 DG393263670.145
 TG56749
Lymphatic dissection
 D1, D1+401323690.334
 D248147
pathological T category
 pT1,2411263850.012
 pT3,438731
pathological N category
 pN0385253600.302
 pN1,2,364856
pathological Stage
 Stage I389253640.005
 Stage II,III60852
Laboratory data
 Day1 (Median)
  WBC (×10/mm3)100101990.186
  CRP (mg/dL)5.754.56.30.057
  Neutrophils (%)83.884.383.60.243
  Lymphocyte (%)10.510110.954
Day3 (Median)
 WBC (×10/mm3)7085680.373
 CRP (mg/dL)7.313.56.30.671
 Neutrophils (%)79.478.749.10.501
 Lymphocyte (%)1512.315.50.079
Difference (Day3-Day1)
 DWBC (×10/mm3)−28−19−320.483
 DCRP1.3990.40.113
 Dneutrophils (×10/mm3)−31−20−310.741
Ratio (Day3/Day1)
 (Median)
  WBC0.70.80.70.844
  CRP1.282.91.10.003
  Neutrophils0.60.70.580.768
Patients characteristics and difference between severe complitcation and no or mild complication

Association of postoperative complications with perioperative background

Postoperative complications are summarized in Table 2. Minor complications (less than CD grade II) included wound site infection, elevated CRP, fever, and intestinal paralysis. Most instances of infectious complications, such as anastomotic leakage and pancreatic fistula, were CD grade III or more. Severe complications (CD grade III or more) occurred in 33 patients (7.3%) (17 cases of anastomotic leakage, 6 cases of pancreatic fistula, 4 cases of intraabdominal abscess, 2 cases of aspiration pneumonia, and 2 cases of strangulation ileus). Three patients showed multiple complications of anastomotic leakage and pancreatic fistula. One patient with CD Grade 5 complications died of cardiac infarction.
Table 2

Postoperative compications

No complicationClavien-Dindo classification
IIIIIIaIIIbIVaIVbV
total3582434221523
Anastomotic leakage001111221
Pancreatic fistula00860000
Intraabdominal abscess00140000
Aspiration Pneumonia00010101
Strangulation ileus00000200
Bleeding00020100
Other0242410001
Postoperative compications We observed no associations of gender, age, or obesity with postoperative complications (Table 1). Complication rates were high in patients with diabetes, patients with renal dysfunction requiring artificial dialysis, and patients with multiple comorbidities, ranging from 15 to 52%. We found no statistical differences in complication rates between patients after laparoscopic total gastrectomy (LTG) and laparoscopic distal gastrectomy (LDG). Anastomotic leakage was observed in 8 cases of LTG and 10 cases of LDG. Although the amount of intraoperative blood loss, operation time, and lymph node dissection showed no correlations, complications occurred frequently in cases where the pathological TNM stage was II/III.

Impact of postoperative laboratory data on complications and predictive value of CRP ratio

No factors in postoperative blood data showed associations with complications, including CRP, white blood cells, and neutrophils, which were considered as markers of bacterial infection. Since blood test data were obtained on POD1 and POD3, the difference and rate of change were calculated and correlations with complications were investigated. No association was identified between changes in WBC, CRP, or neutrophil count, but an association was identified between the CRP ratio and complications (Table 1). Multivariate analysis identified pathological stage, multiple comorbidities, and CRP ratio as independent predictors of severe postoperative complications (Table 3).
Table 3

Multivariate analysis

Standard errorWald-squarep valueOdds ratio95% CI
CRP ratio0.3311.3930.0013.671.7300–7.860
pStage0.3868.1950.0045.61.710–18.400
Multiple Comobidities0.85210.630.0043.271.470–7.280
R2 = 0.117 Pr > ChiSq 0.0002Goodness-of-fit statistics Pr > ChiSq 0.343
Multivariate analysis To determine the optimal cut-off for CRP ratio, we analyzed the ROC curve (Fig. 1a). A cut-off CRP ratio of 2.13 offered 55% sensitivity and 82% specificity for postoperative severe complication, representing the optimal cut-off. The area under curve (AUC) was as low as 0.592, but in comparison, the AUC for CRP on POD3 was 0.489 (Fig. 1b). We then divided patients into two groups: high CRP ratio (≥2.1), 92 patients (20%); and low CRP ratio (< 2.1), 357 patients (80%) (Table 4). Of the 357 patients, 339 showed no complications after surgery, indicating a negative predictive value of 94%. On the other hand, the positive predictive value for postoperative complications was 16%.
Fig. 1

Receiver operating characteristic (ROC) curves for CRP ratio and CRP on postoperative day 3. We used the continuous variable density of CRP ratio (a) and CRP on postoperative day 3 (b) as the test variable and postoperative complications as the state variable. Area under ROC curve was 0.592 for CRP ratio and 0.498 for CRP on postoperative day 3. An investigation of cut-off scores showed the optimal cut-off for CRP ratio was 2.13 (sensitivity, 0.454; specificity, 0.815). We therefore set 2.13 as the cut-off for CRP ratio

Table 4

Predicitive valuse according to CRP elevation ratio

CRP elevation ratio
≥2.13 (n = 92)<2.13 (n = 357)
Severe Complication1518
No or mild comprication77339
Receiver operating characteristic (ROC) curves for CRP ratio and CRP on postoperative day 3. We used the continuous variable density of CRP ratio (a) and CRP on postoperative day 3 (b) as the test variable and postoperative complications as the state variable. Area under ROC curve was 0.592 for CRP ratio and 0.498 for CRP on postoperative day 3. An investigation of cut-off scores showed the optimal cut-off for CRP ratio was 2.13 (sensitivity, 0.454; specificity, 0.815). We therefore set 2.13 as the cut-off for CRP ratio Predicitive valuse according to CRP elevation ratio

Discussion

This study showed a significant association between postoperative CRP elevation and severe postoperative complications after LG. Moreover, CRP ratio, defined here as the ratio of CRP levels on POD1 and POD3, represented an independent risk factor for severe postoperative complications. LG offers various advantages over OG, including shorter duration of hospitalization, reduced blood loss, faster recovery of bowel movement, and earlier ambulation [16]. An updated meta-analysis found no significant difference in postoperative complication rates between LG and OG groups for advanced gastric cancer [17]. Postoperative complications reportedly occurred in 9.8–12.7% of LG patients with stage I or II cancer in two Asian studies [17, 18]. We observed that the complication rate was 14.9% for CD grade II or more and 7.3% for CD grade III or more in the present study. Postoperative intra-abdominal infectious complications such as anastomotic leakage, pancreatic fistula, and intraperitoneal abscess increase surgical stress and cause severe tissue damage due to local and generalized inflammatory reactions, resulting in more severe immune suppression [9]. Numerous studies have identified postoperative CRP concentration as a risk factor for postoperative complications after gastrointestinal cancer surgery, including colorectal cancer, esophageal cancer, and gastric cancer [12, 19–21]. In minimally invasive surgery and laparotomy for colorectal and gastric cancer, postoperative CRP levels have been observed to be significantly lower after minimally invasive surgery if no complications arise [22-24]. Many previous reports on the association between CRP and postoperative infectious complications have involved a mixture of laparotomy and laparoscopic surgery. Of the few reports that have focused on laparoscopic surgery, 300 to 400 cases were examined, with LG accounting for less than 50% of those cases [10, 12, 19]. No marked difference was seen between CRP levels in those reports and levels in laparotomy cases only, and peak CRP concentration is usually observed on POD3 or POD4, with a threshold for predicting complications of 12–17.7 mg/dL [11–13, 25]. Although fewer than 300 cases have previously been reported when limited to laparoscopic surgery, 440 cases were reported in the present study. The significance of this report is considered to be equivalent to that of other reports. Elevated CRP as a predictor of postoperative complications has usually been examined at a single time point. In this study, however, CRP levels on POD3 alone were not associated with complications. One reason for this was likely to be the fact that we examined patients with serious complications other than infectious complications, such as cases requiring reoperation due to severe adhesive ileus, cases of shock due to postoperative bleeding, and cases of death due to myocardial infarction early after surgery. Moreover, high CRP levels were associated with long operation time, greater blood loss, and high BMI. We observed a CRP concentration > 17.5 mg/dL on POD3 in 10% of patients without complications. We therefore focused on the “CRP ratio” to predict postoperative complications. Another reason for using the CRP ratio in this study was the difficulty of setting cut-off values. CRP levels on POD3 were elevated to the same level in both LG and OG groups with and without complications after colorectal cancer surgery, and CRP levels on POD3 were not final predictors of complications [23]. Elevated CRP levels ≥10 mg/dL are generally considered clinically indicative of marked inflammation, but the wide range of cut-off values reported previously can make clinical application of such findings difficult [26]. We showed a negative predictive value of 94% for CRP ratio in this study. As the number of minimally invasive surgeries continues to increase, the length of hospital stays may be shortened. A recently published meta-analysis reported the importance of CRP level on POD3 in predicting readmission after radical gastrectomy [27]. Those results suggest that the CRP elevation rate after surgery may be useful for safely determining early discharge. Several limitations to this study must be considered. This was a single-center, retrospective, observational study and the sample size was small. The power of this study was relatively low, at 0.78, because of the small number of samples. This represents a substantial weakness in the statistical analysis. Validation studies using larger cohorts from multiple centers are needed to confirm the impact of CRP ratio on postoperative complications. Second, only short-term surgical outcomes were evaluated. Pancreatic fistula or intraperitoneal abscess appearing 2 weeks or more after surgery appear unlikely to be anticipated using data from POD3. Third, other parameters that were not assessed included the CRP-to-albumin ratio, estimated glomerular filtration rate, platelet-to-lymphocyte ratio, sarcopenia, and preoperative prealbumin concentration [28-32]. We observed that the complication rate was significantly higher in patients with renal failure on dialysis. Immune response, nutritional condition, and performance status should also be investigated. Despite these limitations, CRP ratio appears potentially useful as an easily understood value for clinical use.

Conclusion

In conclusion, our findings suggested that CRP ratio after laparoscopic gastrectomy could offer a useful predictor of postoperative complications likely to need treatment. Our results suggest that unnecessary treatments such as drain replacement and antibiotics might be obviated when the CRP ratio is low on POD3 after LG.
  32 in total

1.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

2.  Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients.

Authors:  Rene Warschkow; Ulrich Beutner; Thomas Steffen; Sascha A Müller; Bruno M Schmied; Ulrich Güller; Ignazio Tarantino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

3.  A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan.

Authors:  Seigo Kitano; Norio Shiraishi; Ichiro Uyama; Kenichi Sugihara; Nobuhiko Tanigawa
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

4.  Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications.

Authors:  Sumanta Dutta; Grant M Fullarton; Matthew J Forshaw; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

5.  A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results.

Authors:  J-H Lee; H-S Han; J-H Lee
Journal:  Surg Endosc       Date:  2004-12-09       Impact factor: 4.584

Review 6.  What does minor elevation of C-reactive protein signify?

Authors:  Irving Kushner; Debra Rzewnicki; David Samols
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

7.  Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach.

Authors:  M Sierzega; P Kolodziejczyk; J Kulig
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

8.  Major early complications following open, laparoscopic and robotic gastrectomy.

Authors:  K M Kim; J Y An; H I Kim; J H Cheong; W J Hyung; S H Noh
Journal:  Br J Surg       Date:  2012-10-03       Impact factor: 6.939

9.  Cellular and peritoneal immune response after radical laparoscopy-assisted and open gastrectomy for gastric cancer.

Authors:  Il-Kwon Jung; Min-Chan Kim; Kyeong-Hee Kim; Jong-Young Kwak; Ghap-Joong Jung; Hyung-Ho Kim
Journal:  J Surg Oncol       Date:  2008-07-01       Impact factor: 3.454

10.  Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.

Authors:  Young-Woo Kim; Yong Hae Baik; Young Ho Yun; Byung Ho Nam; Dae Hyun Kim; Il Ju Choi; Jae-Moon Bae
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

View more
  3 in total

1.  C-reactive protein adjusted for body mass index as a predictor of postoperative complications following laparoscopic gastrectomy for gastric cancer.

Authors:  Kazuaki Matsui; Shinichi Sakuramoto; Hirofumi Sugita; Keiji Nishibeppu; Gen Ebara; Shohei Fujita; Shiro Fujihata; Shuichiro Oya; Yutaka Miyawaki; Hiroshi Sato; Shigeki Yamaguchi; Keishi Yamashita
Journal:  Langenbecks Arch Surg       Date:  2021-05-21       Impact factor: 3.445

2.  C-reactive protein (CRP) trajectory as a predictor of anastomotic leakage after rectal cancer resection: A multicentre cohort study.

Authors:  Vincent T Hoek; Cloë L Sparreboom; Albert M Wolthuis; Anand G Menon; Gert-Jan Kleinrensink; André D'Hoore; Niels Komen; Johan F Lange
Journal:  Colorectal Dis       Date:  2021-11-07       Impact factor: 3.917

3.  Clinical significance and prognostic value of C-reactive protein/albumin ratio in gastric cancer.

Authors:  Qian Yu; Ke-Zhi Li; Yan-Jun Fu; Yanping Tang; Xin-Qiang Liang; Zhi-Qing Liang; Ji-Hong Bai
Journal:  Ann Surg Treat Res       Date:  2021-06-01       Impact factor: 1.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.